Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Regional Outlook and Forecast, 2023 - 2030

Published Date : 26-Mar-2024

Pages: 250

Formats: PDF

The Global Rabies Vaccine Market size is expected to reach $1.6 billion by 2030, rising at a market growth of 4.5% CAGR during the forecast period.

Pet owners increasingly adopt preventive healthcare practices for their animals, mirroring trends in human healthcare. Regular veterinary visits, including vaccinations, are proactive measures to protect pets from diseases such as rabies, fostering a continuous demand for vaccines. Consequently, the Veterinary clinics segment would acquire nearly, 20% market share by 2030. Advancements in veterinary medicine, including the availability of improved and safer vaccines, contribute to a positive perception of vaccinations among pet owners.

Rabies Vaccine Market Size - Global Opportunities and Trends Analysis Report 2019-2030

Ongoing R&D activities focus on improving the formulation of these vaccines. Researchers work to enhance vaccine stability, reduce adverse reactions, and optimize the immune response. R&D efforts aim to develop next-generation vaccines with enhanced characteristics. This may include vaccines with longer-lasting immunity, novel delivery methods, and the ability to protect against a broader spectrum of rabies virus variants. Therefore, the market is expanding significantly due to the rising research and development (R&D) initiatives. Additionally, Rabies poses a severe threat to human health as it can be transmitted through the saliva of infected animals, primarily through bites or scratches. Zoonotic diseases often transcend national borders, necessitating global collaboration. Collaborative efforts and funding support facilitate the implementation of vaccination programs to control and eliminate rabies, particularly in regions where the disease poses a significant zoonotic threat. Hence, increasing awareness of zoonotic diseases like rabies has been a pivotal factor in driving the growth of the market.

Moreover, The COVID-19 pandemic disrupted routine healthcare services, including vaccination programs. Lockdowns, restrictions on movement, and healthcare system strain may affect the implementation of rabies vaccination campaigns, particularly in regions with limited resources. Travel restrictions and disruptions in global transportation may affected the movement of professionals involved in global health initiatives and collaborations. This impact global efforts to control and eliminate rabies. Thus, the COVID-19 pandemic had a moderate effect on the market.

However, High vaccination program costs can restrict access to these vaccines, particularly in resource-constrained areas. Governments responsible for public health initiatives may experience financial strain when implementing rabies vaccination programs. The allocation of resources to these programs may compete with other essential healthcare needs, potentially leading to budget constraints. Thus, high cost can slow down the growth of the market.

By Prophylaxis Type Analysis

Based on prophylaxis type, the market is classified into pre-exposure prophylaxis and post-exposure prophylaxis. The pre-exposure prophylaxis segment acquired a 40% revenue share in the market in 2022. Pre-exposure prophylaxis offers long-term protection, reducing the need for immediate post-exposure treatment for potential rabies exposure. This long-term protection can be cost-effective in the long run, considering the expenses associated with post-exposure prophylaxis.

By End User Analysis

Based on end user, the market is segmented into hospitals, veterinary clinics, and others. The veterinary clinics segment recorded a 20% revenue share in the market in 2022. A greater demand for veterinary services, such as rabies vaccination, has resulted from the global rise in the prevalence of pet ownership. Routine vaccination programs are integral to the preventive healthcare veterinary clinics provide to pets, including dogs and cats.

Rabies Vaccine Market Share and Industry Analysis Report 2022

By Application Analysis

On the basis of application, the market is bifurcated into human and animal. The animal segment garnered a 30% revenue share in the market in 2022. Animals, particularly mammals, serve as the primary reservoirs of the rabies virus. Controlling rabies in animal populations is essential to reduce the risk of transmission to humans through bites or scratches.

By Product Type Analysis

By product type, the market is categorized into chick embryo cells rabies vaccine, Vero cell rabies vaccine, human diploid cell vaccine, and others. The Vero cell rabies vaccine segment covered a 20% revenue share in the market in 2022. The Vero cell vaccine eliminates the use of nervous tissue in its production, addressing safety concerns associated with traditional nerve tissue-derived vaccines. Removing nervous tissue reduces the risk of adverse reactions, making the Vero cell vaccine a safer option for rabies prevention.

Free Valuable Insights: Global Rabies Vaccine Market size to reach USD 1.6 Billion by 2030

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating 40% revenue share. North America's health authorities and veterinary services implement strategic vaccination programs targeting domestic and wildlife populations. Veterinary clinics and practices across North America actively participate in rabies prevention by providing pet vaccination services.

Rabies Vaccine Market Report Coverage
Report Attribute Details
Market size value in 2022 USD 1.1 Billion
Market size forecast in 2030 USD 1.6 Billion
Base Year 2022
Historical Period 2019 to 2021
Forecast Period 2023 to 2030
Revenue Growth Rate CAGR of 4.5% from 2023 to 2030
Number of Pages 250
Number of Tables 430
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered Product Type, Prophylaxis Type, Application, End User, Region
Country scope
  • North America (US, Canada, Mexico, and Rest of North America)
  • Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Singapore, Malaysia, and Rest of Asia Pacific)
  • LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group), Elanco Animal Health, Inc., Zoetis, Inc., Merck & Co., Inc., Novartis AG, Bharat Biotech Ltd., Sanofi S.A. and Virbac

List of Key Companies Profiled

  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Limited
  • Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
  • Elanco Animal Health, Inc.
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Bharat Biotech Ltd.
  • Sanofi S.A.
  • Virbac

Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

  • Post-exposure Prophylaxis
  • Pre-exposure prophylaxis

By End User

  • Hospitals
  • Veterinary Clinics
  • Others

By Application

  • Human
  • Animal

By Product Type

  • Chick Embryo Cells Rabies Vaccine
  • Human Diploid Cell Vaccine
  • Vero cell rabies vaccine
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Rabies Vaccine Market, by Prophylaxis Type
1.4.2 Global Rabies Vaccine Market, by End User
1.4.3 Global Rabies Vaccine Market, by Application
1.4.4 Global Rabies Vaccine Market, by Product Type
1.4.5 Global Rabies Vaccine Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Global Rabies Vaccine Market by Prophylaxis Type
4.1 Global Post-exposure Prophylaxis Market by Region
4.2 Global Pre-exposure prophylaxis Market by Region

Chapter 5. Global Rabies Vaccine Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Veterinary Clinics Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Rabies Vaccine Market by Application
6.1 Global Human Market by Region
6.2 Global Animal Market by Region

Chapter 7. Global Rabies Vaccine Market by Product Type
7.1 Global Chick Embryo Cells Rabies Vaccine Market by Region
7.2 Global Human Diploid Cell Vaccine Market by Region
7.3 Global Vero Cell Rabies Vaccine Market by Region
7.4 Global Others Market by Region

Chapter 8. Global Rabies Vaccine Market by Region
8.1 North America Rabies Vaccine Market
8.1.1 North America Rabies Vaccine Market by Prophylaxis Type
8.1.1.1 North America Post-exposure Prophylaxis Market by Region
8.1.1.2 North America Pre-exposure prophylaxis Market by Region
8.1.2 North America Rabies Vaccine Market by End User
8.1.2.1 North America Hospitals Market by Country
8.1.2.2 North America Veterinary Clinics Market by Country
8.1.2.3 North America Others Market by Country
8.1.3 North America Rabies Vaccine Market by Application
8.1.3.1 North America Human Market by Country
8.1.3.2 North America Animal Market by Country
8.1.4 North America Rabies Vaccine Market by Product Type
8.1.4.1 North America Chick Embryo Cells Rabies Vaccine Market by Country
8.1.4.2 North America Human Diploid Cell Vaccine Market by Country
8.1.4.3 North America Vero Cell Rabies Vaccine Market by Country
8.1.4.4 North America Others Market by Country
8.1.5 North America Rabies Vaccine Market by Country
8.1.5.1 US Rabies Vaccine Market
8.1.5.1.1 US Rabies Vaccine Market by Prophylaxis Type
8.1.5.1.2 US Rabies Vaccine Market by End User
8.1.5.1.3 US Rabies Vaccine Market by Application
8.1.5.1.4 US Rabies Vaccine Market by Product Type
8.1.5.2 Canada Rabies Vaccine Market
8.1.5.2.1 Canada Rabies Vaccine Market by Prophylaxis Type
8.1.5.2.2 Canada Rabies Vaccine Market by End User
8.1.5.2.3 Canada Rabies Vaccine Market by Application
8.1.5.2.4 Canada Rabies Vaccine Market by Product Type
8.1.5.3 Mexico Rabies Vaccine Market
8.1.5.3.1 Mexico Rabies Vaccine Market by Prophylaxis Type
8.1.5.3.2 Mexico Rabies Vaccine Market by End User
8.1.5.3.3 Mexico Rabies Vaccine Market by Application
8.1.5.3.4 Mexico Rabies Vaccine Market by Product Type
8.1.5.4 Rest of North America Rabies Vaccine Market
8.1.5.4.1 Rest of North America Rabies Vaccine Market by Prophylaxis Type
8.1.5.4.2 Rest of North America Rabies Vaccine Market by End User
8.1.5.4.3 Rest of North America Rabies Vaccine Market by Application
8.1.5.4.4 Rest of North America Rabies Vaccine Market by Product Type
8.2 Europe Rabies Vaccine Market
8.2.1 Europe Rabies Vaccine Market by Prophylaxis Type
8.2.1.1 Europe Post-exposure Prophylaxis Market by Country
8.2.1.2 Europe Pre-exposure prophylaxis Market by Country
8.2.2 Europe Rabies Vaccine Market by End User
8.2.2.1 Europe Hospitals Market by Country
8.2.2.2 Europe Veterinary Clinics Market by Country
8.2.2.3 Europe Others Market by Country
8.2.3 Europe Rabies Vaccine Market by Application
8.2.3.1 Europe Human Market by Country
8.2.3.2 Europe Animal Market by Country
8.2.4 Europe Rabies Vaccine Market by Product Type
8.2.4.1 Europe Chick Embryo Cells Rabies Vaccine Market by Country
8.2.4.2 Europe Human Diploid Cell Vaccine Market by Country
8.2.4.3 Europe Vero Cell Rabies Vaccine Market by Country
8.2.4.4 Europe Others Market by Country
8.2.5 Europe Rabies Vaccine Market by Country
8.2.5.1 Germany Rabies Vaccine Market
8.2.5.1.1 Germany Rabies Vaccine Market by Prophylaxis Type
8.2.5.1.2 Germany Rabies Vaccine Market by End User
8.2.5.1.3 Germany Rabies Vaccine Market by Application
8.2.5.1.4 Germany Rabies Vaccine Market by Product Type
8.2.5.2 UK Rabies Vaccine Market
8.2.5.2.1 UK Rabies Vaccine Market by Prophylaxis Type
8.2.5.2.2 UK Rabies Vaccine Market by End User
8.2.5.2.3 UK Rabies Vaccine Market by Application
8.2.5.2.4 UK Rabies Vaccine Market by Product Type
8.2.5.3 France Rabies Vaccine Market
8.2.5.3.1 France Rabies Vaccine Market by Prophylaxis Type
8.2.5.3.2 France Rabies Vaccine Market by End User
8.2.5.3.3 France Rabies Vaccine Market by Application
8.2.5.3.4 France Rabies Vaccine Market by Product Type
8.2.5.4 Russia Rabies Vaccine Market
8.2.5.4.1 Russia Rabies Vaccine Market by Prophylaxis Type
8.2.5.4.2 Russia Rabies Vaccine Market by End User
8.2.5.4.3 Russia Rabies Vaccine Market by Application
8.2.5.4.4 Russia Rabies Vaccine Market by Product Type
8.2.5.5 Spain Rabies Vaccine Market
8.2.5.5.1 Spain Rabies Vaccine Market by Prophylaxis Type
8.2.5.5.2 Spain Rabies Vaccine Market by End User
8.2.5.5.3 Spain Rabies Vaccine Market by Application
8.2.5.5.4 Spain Rabies Vaccine Market by Product Type
8.2.5.6 Italy Rabies Vaccine Market
8.2.5.6.1 Italy Rabies Vaccine Market by Prophylaxis Type
8.2.5.6.2 Italy Rabies Vaccine Market by End User
8.2.5.6.3 Italy Rabies Vaccine Market by Application
8.2.5.6.4 Italy Rabies Vaccine Market by Product Type
8.2.5.7 Rest of Europe Rabies Vaccine Market
8.2.5.7.1 Rest of Europe Rabies Vaccine Market by Prophylaxis Type
8.2.5.7.2 Rest of Europe Rabies Vaccine Market by End User
8.2.5.7.3 Rest of Europe Rabies Vaccine Market by Application
8.2.5.7.4 Rest of Europe Rabies Vaccine Market by Product Type
8.3 Asia Pacific Rabies Vaccine Market
8.3.1 Asia Pacific Rabies Vaccine Market by Prophylaxis Type
8.3.1.1 Asia Pacific Post-exposure Prophylaxis Market by Country
8.3.1.2 Asia Pacific Pre-exposure prophylaxis Market by Country
8.3.2 Asia Pacific Rabies Vaccine Market by End User
8.3.2.1 Asia Pacific Hospitals Market by Country
8.3.2.2 Asia Pacific Veterinary Clinics Market by Country
8.3.2.3 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Rabies Vaccine Market by Application
8.3.3.1 Asia Pacific Human Market by Country
8.3.3.2 Asia Pacific Animal Market by Country
8.3.4 Asia Pacific Rabies Vaccine Market by Product Type
8.3.4.1 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country
8.3.4.2 Asia Pacific Human Diploid Cell Vaccine Market by Country
8.3.4.3 Asia Pacific Vero Cell Rabies Vaccine Market by Country
8.3.4.4 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Rabies Vaccine Market by Country
8.3.5.1 China Rabies Vaccine Market
8.3.5.1.1 China Rabies Vaccine Market by Prophylaxis Type
8.3.5.1.2 China Rabies Vaccine Market by End User
8.3.5.1.3 China Rabies Vaccine Market by Application
8.3.5.1.4 China Rabies Vaccine Market by Product Type
8.3.5.2 Japan Rabies Vaccine Market
8.3.5.2.1 Japan Rabies Vaccine Market by Prophylaxis Type
8.3.5.2.2 Japan Rabies Vaccine Market by End User
8.3.5.2.3 Japan Rabies Vaccine Market by Application
8.3.5.2.4 Japan Rabies Vaccine Market by Product Type
8.3.5.3 India Rabies Vaccine Market
8.3.5.3.1 India Rabies Vaccine Market by Prophylaxis Type
8.3.5.3.2 India Rabies Vaccine Market by End User
8.3.5.3.3 India Rabies Vaccine Market by Application
8.3.5.3.4 India Rabies Vaccine Market by Product Type
8.3.5.4 South Korea Rabies Vaccine Market
8.3.5.4.1 South Korea Rabies Vaccine Market by Prophylaxis Type
8.3.5.4.2 South Korea Rabies Vaccine Market by End User
8.3.5.4.3 South Korea Rabies Vaccine Market by Application
8.3.5.4.4 South Korea Rabies Vaccine Market by Product Type
8.3.5.5 Singapore Rabies Vaccine Market
8.3.5.5.1 Singapore Rabies Vaccine Market by Prophylaxis Type
8.3.5.5.2 Singapore Rabies Vaccine Market by End User
8.3.5.5.3 Singapore Rabies Vaccine Market by Application
8.3.5.5.4 Singapore Rabies Vaccine Market by Product Type
8.3.5.6 Malaysia Rabies Vaccine Market
8.3.5.6.1 Malaysia Rabies Vaccine Market by Prophylaxis Type
8.3.5.6.2 Malaysia Rabies Vaccine Market by End User
8.3.5.6.3 Malaysia Rabies Vaccine Market by Application
8.3.5.6.4 Malaysia Rabies Vaccine Market by Product Type
8.3.5.7 Rest of Asia Pacific Rabies Vaccine Market
8.3.5.7.1 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type
8.3.5.7.2 Rest of Asia Pacific Rabies Vaccine Market by End User
8.3.5.7.3 Rest of Asia Pacific Rabies Vaccine Market by Application
8.3.5.7.4 Rest of Asia Pacific Rabies Vaccine Market by Product Type
8.4 LAMEA Rabies Vaccine Market
8.4.1 LAMEA Rabies Vaccine Market by Prophylaxis Type
8.4.1.1 LAMEA Post-exposure Prophylaxis Market by Country
8.4.1.2 LAMEA Pre-exposure prophylaxis Market by Country
8.4.2 LAMEA Rabies Vaccine Market by End User
8.4.2.1 LAMEA Hospitals Market by Country
8.4.2.2 LAMEA Veterinary Clinics Market by Country
8.4.2.3 LAMEA Others Market by Country
8.4.3 LAMEA Rabies Vaccine Market by Application
8.4.3.1 LAMEA Human Market by Country
8.4.3.2 LAMEA Animal Market by Country
8.4.4 LAMEA Rabies Vaccine Market by Product Type
8.4.4.1 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country
8.4.4.2 LAMEA Human Diploid Cell Vaccine Market by Country
8.4.4.3 LAMEA Vero Cell Rabies Vaccine Market by Country
8.4.4.4 LAMEA Others Market by Country
8.4.5 LAMEA Rabies Vaccine Market by Country
8.4.5.1 Brazil Rabies Vaccine Market
8.4.5.1.1 Brazil Rabies Vaccine Market by Prophylaxis Type
8.4.5.1.2 Brazil Rabies Vaccine Market by End User
8.4.5.1.3 Brazil Rabies Vaccine Market by Application
8.4.5.1.4 Brazil Rabies Vaccine Market by Product Type
8.4.5.2 Argentina Rabies Vaccine Market
8.4.5.2.1 Argentina Rabies Vaccine Market by Prophylaxis Type
8.4.5.2.2 Argentina Rabies Vaccine Market by End User
8.4.5.2.3 Argentina Rabies Vaccine Market by Application
8.4.5.2.4 Argentina Rabies Vaccine Market by Product Type
8.4.5.3 UAE Rabies Vaccine Market
8.4.5.3.1 UAE Rabies Vaccine Market by Prophylaxis Type
8.4.5.3.2 UAE Rabies Vaccine Market by End User
8.4.5.3.3 UAE Rabies Vaccine Market by Application
8.4.5.3.4 UAE Rabies Vaccine Market by Product Type
8.4.5.4 Saudi Arabia Rabies Vaccine Market
8.4.5.4.1 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type
8.4.5.4.2 Saudi Arabia Rabies Vaccine Market by End User
8.4.5.4.3 Saudi Arabia Rabies Vaccine Market by Application
8.4.5.4.4 Saudi Arabia Rabies Vaccine Market by Product Type
8.4.5.5 South Africa Rabies Vaccine Market
8.4.5.5.1 South Africa Rabies Vaccine Market by Prophylaxis Type
8.4.5.5.2 South Africa Rabies Vaccine Market by End User
8.4.5.5.3 South Africa Rabies Vaccine Market by Application
8.4.5.5.4 South Africa Rabies Vaccine Market by Product Type
8.4.5.6 Nigeria Rabies Vaccine Market
8.4.5.6.1 Nigeria Rabies Vaccine Market by Prophylaxis Type
8.4.5.6.2 Nigeria Rabies Vaccine Market by End User
8.4.5.6.3 Nigeria Rabies Vaccine Market by Application
8.4.5.6.4 Nigeria Rabies Vaccine Market by Product Type
8.4.5.7 Rest of LAMEA Rabies Vaccine Market
8.4.5.7.1 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type
8.4.5.7.2 Rest of LAMEA Rabies Vaccine Market by End User
8.4.5.7.3 Rest of LAMEA Rabies Vaccine Market by Application
8.4.5.7.4 Rest of LAMEA Rabies Vaccine Market by Product Type

Chapter 9. Company Profiles
9.1 Cadila Pharmaceuticals Limited
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.2 Bharat Biotech Ltd.
9.2.1 Company Overview
9.3 Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
9.3.1 Company Overview
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Elanco Animal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Zoetis, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Virbac
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 SWOT Analysis

Chapter 10. Winning imperative of Rabies Vaccine Market
TABLE 1 Global Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2 Global Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3 Global Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4 Global Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5 Global Post-exposure Prophylaxis Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Post-exposure Prophylaxis Market by Region, 2023 - 2030, USD Million
TABLE 7 Global Pre-exposure prophylaxis Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Pre-exposure prophylaxis Market by Region, 2023 - 2030, USD Million
TABLE 9 Global Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10 Global Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11 Global Hospitals Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Hospitals Market by Region, 2023 - 2030, USD Million
TABLE 13 Global Veterinary Clinics Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Veterinary Clinics Market by Region, 2023 - 2030, USD Million
TABLE 15 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 17 Global Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18 Global Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19 Global Human Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Human Market by Region, 2023 - 2030, USD Million
TABLE 21 Global Animal Market by Region, 2019 - 2022, USD Million
TABLE 22 Global Animal Market by Region, 2023 - 2030, USD Million
TABLE 23 Global Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24 Global Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25 Global Chick Embryo Cells Rabies Vaccine Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Chick Embryo Cells Rabies Vaccine Market by Region, 2023 - 2030, USD Million
TABLE 27 Global Human Diploid Cell Vaccine Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Human Diploid Cell Vaccine Market by Region, 2023 - 2030, USD Million
TABLE 29 Global Vero Cell Rabies Vaccine Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Vero Cell Rabies Vaccine Market by Region, 2023 - 2030, USD Million
TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 33 Global Rabies Vaccine Market by Region, 2019 - 2022, USD Million
TABLE 34 Global Rabies Vaccine Market by Region, 2023 - 2030, USD Million
TABLE 35 North America Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36 North America Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37 North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38 North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39 North America Post-exposure Prophylaxis Market by Region, 2019 - 2022, USD Million
TABLE 40 North America Post-exposure Prophylaxis Market by Region, 2023 - 2030, USD Million
TABLE 41 North America Pre-exposure prophylaxis Market by Region, 2019 - 2022, USD Million
TABLE 42 North America Pre-exposure prophylaxis Market by Region, 2023 - 2030, USD Million
TABLE 43 North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 44 North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 45 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 51 North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52 North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53 North America Human Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Human Market by Country, 2023 - 2030, USD Million
TABLE 55 North America Animal Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Animal Market by Country, 2023 - 2030, USD Million
TABLE 57 North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 58 North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 59 North America Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 61 North America Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 62 North America Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 63 North America Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 64 North America Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 65 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 66 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 67 North America Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 68 North America Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 69 US Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 70 US Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 71 US Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 72 US Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 73 US Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 74 US Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 75 US Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 76 US Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 77 US Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 78 US Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 79 Canada Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 80 Canada Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 81 Canada Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 82 Canada Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 83 Canada Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 84 Canada Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 85 Canada Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 86 Canada Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 87 Canada Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 88 Canada Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 89 Mexico Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 90 Mexico Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 91 Mexico Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 92 Mexico Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 93 Mexico Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 94 Mexico Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 95 Mexico Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 96 Mexico Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 97 Mexico Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 98 Mexico Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 99 Rest of North America Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 100 Rest of North America Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 101 Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 102 Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 103 Rest of North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 104 Rest of North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 105 Rest of North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 106 Rest of North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 107 Rest of North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 108 Rest of North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 109 Europe Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 110 Europe Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 111 Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 112 Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 113 Europe Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 115 Europe Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 117 Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 118 Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 119 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 121 Europe Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 122 Europe Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 125 Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 126 Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 127 Europe Human Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Human Market by Country, 2023 - 2030, USD Million
TABLE 129 Europe Animal Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe Animal Market by Country, 2023 - 2030, USD Million
TABLE 131 Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 132 Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 133 Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 134 Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 135 Europe Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 136 Europe Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 137 Europe Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 138 Europe Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 139 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 140 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 141 Europe Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 142 Europe Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 143 Germany Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 144 Germany Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 145 Germany Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 146 Germany Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 147 Germany Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 148 Germany Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 149 Germany Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 150 Germany Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 151 Germany Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 152 Germany Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 153 UK Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 154 UK Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 155 UK Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 156 UK Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 157 UK Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 158 UK Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 159 UK Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 160 UK Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 161 UK Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 162 UK Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 163 France Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 164 France Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 165 France Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 166 France Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 167 France Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 168 France Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 169 France Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 170 France Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 171 France Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 172 France Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 173 Russia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 174 Russia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 175 Russia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 176 Russia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 177 Russia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 178 Russia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 179 Russia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 180 Russia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 181 Russia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 182 Russia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 183 Spain Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 184 Spain Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 185 Spain Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 186 Spain Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 187 Spain Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 188 Spain Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 189 Spain Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 190 Spain Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 191 Spain Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 192 Spain Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 193 Italy Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 194 Italy Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 195 Italy Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 196 Italy Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 197 Italy Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 198 Italy Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 199 Italy Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 200 Italy Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 201 Italy Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 202 Italy Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 203 Rest of Europe Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 204 Rest of Europe Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 205 Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 206 Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 207 Rest of Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 208 Rest of Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 209 Rest of Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 210 Rest of Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 211 Rest of Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 212 Rest of Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 213 Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 215 Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 217 Asia Pacific Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 219 Asia Pacific Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 221 Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 223 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 225 Asia Pacific Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 227 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 229 Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 231 Asia Pacific Human Market by Country, 2019 - 2022, USD Million
TABLE 232 Asia Pacific Human Market by Country, 2023 - 2030, USD Million
TABLE 233 Asia Pacific Animal Market by Country, 2019 - 2022, USD Million
TABLE 234 Asia Pacific Animal Market by Country, 2023 - 2030, USD Million
TABLE 235 Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 236 Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 237 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 238 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 239 Asia Pacific Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 240 Asia Pacific Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 241 Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 242 Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 243 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 244 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 245 Asia Pacific Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 246 Asia Pacific Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 247 China Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 248 China Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 249 China Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 250 China Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 251 China Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 252 China Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 253 China Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 254 China Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 255 China Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 256 China Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 257 Japan Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 258 Japan Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 259 Japan Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 260 Japan Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 261 Japan Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 262 Japan Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 263 Japan Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 264 Japan Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 265 Japan Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 266 Japan Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 267 India Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 268 India Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 269 India Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 270 India Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 271 India Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 272 India Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 273 India Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 274 India Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 275 India Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 276 India Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 277 South Korea Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 278 South Korea Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 279 South Korea Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 280 South Korea Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 281 South Korea Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 282 South Korea Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 283 South Korea Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 284 South Korea Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 285 South Korea Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 286 South Korea Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 287 Singapore Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 288 Singapore Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 289 Singapore Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 290 Singapore Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 291 Singapore Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 292 Singapore Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 293 Singapore Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 294 Singapore Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 295 Singapore Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 296 Singapore Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 297 Malaysia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 298 Malaysia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 299 Malaysia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 300 Malaysia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 301 Malaysia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 302 Malaysia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 303 Malaysia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 304 Malaysia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 305 Malaysia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 306 Malaysia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 307 Rest of Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 308 Rest of Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 309 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 310 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 311 Rest of Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 312 Rest of Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 313 Rest of Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 314 Rest of Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 315 Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 316 Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 317 LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 318 LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 319 LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 320 LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 321 LAMEA Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 322 LAMEA Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 323 LAMEA Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 324 LAMEA Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 325 LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 326 LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 327 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 328 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 329 LAMEA Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 330 LAMEA Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 331 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 332 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 333 LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 334 LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 335 LAMEA Human Market by Country, 2019 - 2022, USD Million
TABLE 336 LAMEA Human Market by Country, 2023 - 2030, USD Million
TABLE 337 LAMEA Animal Market by Country, 2019 - 2022, USD Million
TABLE 338 LAMEA Animal Market by Country, 2023 - 2030, USD Million
TABLE 339 LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 340 LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 341 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 342 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 343 LAMEA Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 344 LAMEA Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 345 LAMEA Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 346 LAMEA Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 347 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 348 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 349 LAMEA Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 350 LAMEA Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 351 Brazil Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 352 Brazil Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 353 Brazil Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 354 Brazil Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 355 Brazil Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 356 Brazil Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 357 Brazil Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 358 Brazil Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 359 Brazil Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 360 Brazil Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 361 Argentina Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 362 Argentina Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 363 Argentina Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 364 Argentina Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 365 Argentina Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 366 Argentina Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 367 Argentina Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 368 Argentina Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 369 Argentina Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 370 Argentina Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 371 UAE Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 372 UAE Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 373 UAE Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 374 UAE Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 375 UAE Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 376 UAE Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 377 UAE Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 378 UAE Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 379 UAE Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 380 UAE Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 381 Saudi Arabia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 382 Saudi Arabia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 383 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 384 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 385 Saudi Arabia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 386 Saudi Arabia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 387 Saudi Arabia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 388 Saudi Arabia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 389 Saudi Arabia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 390 Saudi Arabia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 391 South Africa Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 392 South Africa Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 393 South Africa Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 394 South Africa Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 395 South Africa Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 396 South Africa Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 397 South Africa Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 398 South Africa Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 399 South Africa Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 400 South Africa Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 401 Nigeria Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 402 Nigeria Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 403 Nigeria Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 404 Nigeria Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 405 Nigeria Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 406 Nigeria Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 407 Nigeria Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 408 Nigeria Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 409 Nigeria Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 410 Nigeria Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 411 Rest of LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 412 Rest of LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 413 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 414 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 415 Rest of LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 416 Rest of LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 417 Rest of LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 418 Rest of LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 419 Rest of LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 420 Rest of LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 421 Key Information – Cadila Pharmaceuticals Limited
TABLE 422 Key Information – Bharat Biotech Ltd.
TABLE 423 Key Information – Serum Institute of India Pvt. Ltd.
TABLE 424 Key Information – Boehringer Ingelheim International GmbH
TABLE 425 Key information – Elanco Animal Health, Inc.
TABLE 426 Key Information – Zoetis, Inc.
TABLE 427 Key Information - Merck & Co., Inc.
TABLE 428 Key Information – Novartis AG
TABLE 429 Key Information – Sanofi S.A.
TABLE 430 Key Information – Virbac

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Rabies Vaccine Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Rabies Vaccine Market
FIG 4 Porter’s Five Forces Analysis – Rabies Vaccine Market
FIG 5 Global Rabies Vaccine Market share by Prophylaxis Type, 2022
FIG 6 Global Rabies Vaccine Market share by Prophylaxis Type, 2030
FIG 7 Global Rabies Vaccine Market by Prophylaxis Type, 2019 - 2030, USD Million
FIG 8 Global Rabies Vaccine Market share by End User, 2022
FIG 9 Global Rabies Vaccine Market share by End User, 2030
FIG 10 Global Rabies Vaccine Market by End User, 2019 - 2030, USD Million
FIG 11 Global Rabies Vaccine Market share by Application, 2022
FIG 12 Global Rabies Vaccine Market share by Application, 2030
FIG 13 Global Rabies Vaccine Market by Application, 2019 - 2030, USD Million
FIG 14 Global Rabies Vaccine Market share by Product Type, 2022
FIG 15 Global Rabies Vaccine Market share by Product Type, 2030
FIG 16 Global Rabies Vaccine Market by Product Type, 2019 - 2030, USD Million
FIG 17 Global Rabies Vaccine Market share by Region, 2022
FIG 18 Global Rabies Vaccine Market share by Region, 2030
FIG 19 Global Rabies Vaccine Market by Region, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Elanco Animal Health, Inc.
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Novartis AG
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis: Virbac

Purchase Full Report of
Rabies Vaccine Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL